These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33116488)

  • 1. Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells.
    Lan MY; Hsu YB; Lan MC; Chen JP; Lu YJ
    Int J Nanomedicine; 2020; 15():7569-7582. PubMed ID: 33116488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma.
    Hsu YB; Lan MC; Kuo YL; Huang CF; Lan MY
    Invest New Drugs; 2020 Apr; 38(2):264-273. PubMed ID: 30993588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
    Yin P; Song G; Jiang Z
    Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized Graphene Oxide as a nanocarrier of new Copper (II) complexes for targeted therapy on nasopharyngeal carcinoma.
    Li G; Yang Y; Zhou R; Meng F; Li X
    Eur J Pharm Sci; 2018 Oct; 123():249-259. PubMed ID: 29981404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific super-enhancer actuated by berberine regulates EGFR-mediated RAS-RAF1-MEK1/2-ERK1/2 pathway to induce nasopharyngeal carcinoma autophagy.
    Wu Y; Jia Q; Tang Q; Chen L; Deng H; He Y; Tang F
    Cell Mol Biol Lett; 2024 Jun; 29(1):92. PubMed ID: 38943090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
    Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
    Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
    [No Abstract]   [Full Text] [Related]  

  • 7. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
    Li T; Li Y
    Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolfenamic Acid Inhibits the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma: Involvement of p38-Mediated Down-Regulation of Slug.
    Jittreetat T; Shin YS; Hwang HS; Lee BS; Kim YS; Sannikorn P; Kim CH
    Yonsei Med J; 2016 May; 57(3):588-98. PubMed ID: 26996556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
    Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
    Zhou D; Ye C; Pan Z; Deng Y
    Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
    [No Abstract]   [Full Text] [Related]  

  • 12. m 6 A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2.
    Zhao C; Zhang F; Tian Y; Tang B; Luo J; Zhang J
    Anticancer Drugs; 2024 Jul; 35(6):501-511. PubMed ID: 38478015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
    Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoliquiritigenin diminishes invasiveness of human nasopharyngeal carcinoma cells associating with inhibition of MMP-2 expression and STAT3 signalling.
    Lu YT; Hsin CH; Kao SH; Ho YT; Yeh FL; Yang SF; Lin CW
    J Cell Mol Med; 2024 Aug; 28(15):e18586. PubMed ID: 39121240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin-targeting redox hyperbranched poly(amido amine)-functionalized graphene oxide for sensitized chemotherapy combined with gene therapy to nasopharyngeal carcinoma.
    Liu T; Li J; Wu X; Zhang S; Lu Z; Li G; Li J; Chen S
    Drug Deliv; 2019 Dec; 26(1):744-755. PubMed ID: 31340676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
    Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
    Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morusin Suppresses Cancer Cell Invasion and MMP-2 Expression through ERK Signaling in Human Nasopharyngeal Carcinoma.
    Huang CC; Wang PH; Lu YT; Yang JS; Yang SF; Ho YT; Lin CW; Hsin CH
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33096744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.